News

roofPilot and Citeline Connect, the most comprehensive solution for clinical trial engagement and recruitment, announced a strategic partnership to make clinical trials more accessible…
Read More...

Good Therapeutics, a privately held company, announced it has entered into a definitive merger agreement to be acquired by Roche. With this acquisition, Roche will gain rights to Good…
Read More...

Tetra Bio-Pharma Inc. announced they signed an agreement with Cellvera Global Holdings LLC ("Cellvera"), for the co-development of ARDS-003 as a combination product, with Qifenda 400MG…
Read More...

AceLink Therapeutics, Inc. (AceLink), an innovative biopharmaceutical company developing transformative therapies for genetic diseases, announced it has received Orphan Drug Designation…
Read More...

Advanco SA announced that it is partnering with Vantage Solutions to provide the first open, interoperable, and secure traceability solution for the Pharmaceutical Industry. advanco is…
Read More...

Evaxion Biotech A/S announced that the Company, in collaboration with UMass Chan Medical School, has received a grant from the U.S. National Institutes of Health (“NIH”) for the…
Read More...

Curavit Clinical Research, a virtual contract research organization (VCRO), has entered into a long-term partnership with ixlayer to provide easy access to clinical-grade diagnostic lab…
Read More...

NaNotics LLC, a biopharmaceutical company developing NaNots, novel subtractive nanoparticles that treat disease by capturing and clearing pathogenic molecules from blood, announced a…
Read More...

Kite, a Gilead Company announced that the European Commission (EC) has approved its CAR T-cell therapy Tecartus (brexucabtagene autoleucel) for the treatment of adult patients 26 years…
Read More...

Bertis, a proteomics-based precision medicine technology development company (CEOs Dong-young Noh, Seung-man Han), announced on the 5th that the research results of their search for…
Read More...

InnoCare Pharma announced that BTK inhibitor orelabrutinib has been granted priority review for the treatment of relapsed or refractory Marginal Zone Lymphoma (R/R MZL) by the Center…
Read More...

AstraZeneca’s Forxiga (dapagliflozin), a sodium-glucose cotransporter 2 (SGLT2) inhibitor, has been approved in China to reduce the risk of sustained estimated glomerular filtration…
Read More...

CARsgen Therapeutics Holdings Limited announces that the company’s Current Good Manufacturing Practice (CGMP) manufacturing facility located at the Research Triangle Park (RTP) in North…
Read More...

Azurity Pharmaceuticals, a pharmaceutical company focused on developing innovative dose-forms and formulations of products to serve the needs of overlooked patients, announced that the…
Read More...

Vertex Pharmaceuticals Incorporated announced the U.S. Food and Drug Administration (FDA) approved expanded use of ORKAMBI (lumacaftor/ivacaftor) to include children with cystic…
Read More...

AstraZeneca’s Imfinzi (durvalumab) has been approved in the US for the treatment of adult patients with locally advanced or metastatic biliary tract cancer (BTC) in combination with…
Read More...

Avacta Group plc, a clinical stage oncology drug company and developer of powerful diagnostics based on its innovative Affimer and pre|CISION platforms, announces that the US Food and…
Read More...

Boehringer Ingelheim announced the U.S. Food and Drug Administration has approved SPEVIGO, the first approved treatment option for generalized pustular psoriasis (GPP) flares in adults.…
Read More...

Boehringer Ingelheim announced the U.S. Food and Drug Administration has approved SPEVIGO, the first approved treatment option for generalized pustular psoriasis (GPP) flares in adults.…
Read More...

Cambrex announced the completion of the first phase of its $30 million investment in its small molecule active pharmaceutical ingredient (API) manufacturing facility in High Point,…
Read More...